Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer

• Prif Awduron: Jeyachandran Dhanapriya (Awdur), Sankarakumar GaneshAravind (Awdur), Thanigachalam Dineshkumar (Awdur), Ramanathan Sakthirajan (Awdur), Balasubramaniyan T (Awdur), Natarajan Gopalakrishnan (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Archives of Clinical Nephrology - Peertechz Publications, 2017-03-27.
• Pynciau: Case Report
• Mynediad Ar-lein: Connect to this object online.

<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....